Quick Answer
Whitehawk Therapeutics, Inc. reported Total Assets of $150.83 million for fiscal year 2025.
Whitehawk Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $150.83M | +114.5% |
| 2024 | $70.32M | -46.9% |
| 2023 | $132.42M | -28.1% |
| 2022 | $184.24M | +16.7% |
| 2021 | $157.91M | +738.8% |
| 2020 | $18.82M | -52.9% |
| 2019 | $39.94M | -37.7% |
| 2018 | $64.12M | +204.9% |
| 2017 | $21.03M | +777.3% |
| 2016 | $2.40M | +12835.8% |
| 2015 | $18.5K | +252.1% |
| 2014 | $5.3K | -40.1% |
| 2013 | $8.8K | +8.3% |
| 2012 | $8.1K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $167.02M | +94.9% | -7.6% |
| June 30, 2025 | $180.82M | +77.9% | -22.7% |
| March 31, 2025 | $234.00M | +110.7% | +232.8% |
| December 31, 2024 | $70.32M | -46.9% | -17.9% |
| September 30, 2024 | $85.70M | -38.6% | -15.7% |
| June 30, 2024 | $101.62M | -32.8% | -8.5% |
| March 31, 2024 | $111.07M | -34.9% | -16.1% |
| December 31, 2023 | $132.42M | -28.1% | -5.2% |
- Whitehawk Therapeutics, Inc. showed an increase of +114.5% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Whitehawk Therapeutics, Inc.’s total assets has grown by 1860390.9% (from $8.1 thousand to $150.83 million).
- The most recent figure is from Whitehawk Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: